Evidence map›Paper›PMID 37855897›Full record

Trial reportWorld journal of urology2023

Thulium fiber laser vs Ho:YAG in RIRS: a prospective randomized clinical trial assessing the efficacy of lasers and different fiber diameters (150 µm and 200 µm).

Mark Taratkin, Camilla Azilgareeva, Vladislav Petov, Andrey Morozov, Stanislav Ali, Diana Babaevskaya, Vincent De Coninck, Dmitry Korolev, Gagik Akopyan, Cesare Marco Scoffone and 6 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in World journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Adoption of thulium fiber laser for lithotripsy A scoping review and bibliometric analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 5 countries.

Mark TaratkinInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Camilla AzilgareevaInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Vladislav PetovInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Andrey MorozovInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Stanislav AliInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Diana BabaevskayaInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Vincent De ConinckDepartment of Urology, AZ Klina, Brasschaat, Belgium.
Dmitry KorolevInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Gagik AkopyanInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Cesare Marco ScoffoneDepartment of Urology, Cottolengo Hospital, Turin, Italy.
Denis ChinenovInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Alexander AndrosovSechenov University, Moscow, Russia.
Harun FajkovicDepartment of Urology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
David LifshitzDivision of Urology, Rabin Medical Center, Petach Tikva, Israel.
Olivier TraxerGRC #20 Lithiase Urinaire, Sorbonne University, Hôpital Tenon, Paris, France.
Dmitry EnikeevInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. dvenikeev@gmail.com.ORCID http://orcid.org/0000-0001-7169-2209
Sechenov University · RUAZ Klina · BEKarl Landsteiner Society · ATSorbonne Université · FRTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aims of the study: (1) to compare the Super Pulse Thulium Fiber Laser (SP TFL) and the holmium: yttrium-aluminium-garnet (Ho:YAG) lasers in retrograde intrarenal surgery (RIRS); (2) to compare the efficacy of SP TFL laser fibers of different diameters (150 μm and 200 μm).

methodsA prospective randomized single-blinded trial was conducted. Patients with stones from 10 to 20 mm were randomly assigned RIRS in three groups: (1) SP TFL (NTO IRE-Polus, Russia) with fiber diameter of 150 μm; (2) SP TFL with 200-μm fiber; and (3) Ho:YAG (Lumenis, USA) with 200-μm fiber.

resultsNinety-six patients with kidney stones were randomized to undergo RIRS with SP TFL using a 150-μm fiber (34 patients) and a 200-μm fiber (32 patients) and RIRS with Ho:YAG (30 patients). The median laser on time (LOT) in the 200-μm SP TFL group was 9.2 (6.2-14.6) min, in 150-μm SP TFL-11.4 (7.7-14.9) min (p = 0.390), in Ho:YAG-14.1 (10.8-18.1) min (p = 0.021). The total energy consumed in 200-μm SP TFL was 8.4 (5.8-15.2) kJ; 150-μm SP TFL - 10.8 (7.3-13.5) kJ (p = 0.626) and in Ho:YAG-15.2 (11.1-25.3) kJ (p = 0.005).

conclusionsIrrespective of the density, RIRS with SP TFL laser has proven to be both a safe and effective procedure. Whilst the introduction of smaller fibers may have the potential to reduce the duration of surgery, SP TFL results in a reduction in the LOT and total energy for stone ablation in RIRS compared with Ho:YAG.

Indexed as

Kidney CalculiLasers, Solid-StateLithotripsy, LaserHolmiumHumansProspective StudiesThuliumHolmiumThuliumHo:YAGRIRSThulium fiber laser

Identifiers

PMID37855897
PMCPMC10693522
OpenAlexW4387765439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.